IL7 and neoplasm: Analogous to these results, CAR T cells cultured in IL-7/IL-15 generated more TCM-like cells and showed an improved response to αPD-1 therapy following transfer into tumor-bearing mice, compared with cells preconditioned in IL-2/IL-15 (58).